Greg Scott - President & Founder, ChinaBio? LLC
講演者とフォーラム参加者：
Leon Chen, PhD - Partner, Fidelity Asia Ventures
Li Chen, PhD - President & CEO, Hua Medicine Ltd.
Peng Chen, PhD, JD – Partner, Morrison & Foerster LLP
Francine Fang, MD, PhD - Senior Consultant, TusPark Ventures
Alex Fowkes, JD - Executive Director, Head of R&D Business Development, Pfizer Global Research & Development
Jian Han, MD, PhD - President & CSO, iCubate Inc.
Jennifer Hu, PhD - Director of Licensing & External Research, Merck & Co., Inc., USA
Kewen Jin, PhD - General Manager, Charles River Greater China
Karen Liu, PhD - VP, China Renaissance Capital Investment
Yuwen Liu, MBA - Chairwoman & CEO, BioBay
Peter (Peizhi) Luo, PhD - Founder & Chairman, Adagene Inc.
Jie Mi, PhD, MBA - Vice President, Gold Stone Investment Co.
Joshua Ning, MBA - President & CEO, Suzhou DingMind Co., Ltd.
Marc A. Schueler, MD, PhD, MBA - Director Venturing, DSM
Victor Shi, PhD - President, Asia Pacific, QIAGEN
Timothy Wong, PhD - Marketing Development Manager, Drug Discovery, Pharma and CRO, Asia Pacific Invitrogen, by Life Technologies
Chun Wu, PhD - Founder & CEO, Abgent Biotech (SuZhou) Co., Ltd.
Bai Xu, PhD - President & CEO, Suzhou Natong Nanobiotechnology Co., Ltd.
David Xu, PhD - Managing Partner, Mingly China Growth Fund
Stella Xu, PhD - Executive Director, Roche Global Pharma Partnering
Yanning Yi, MBA - Executive Director, The Balloch Group
Jason Zhao, MBA - Investment Director, SB China Venture Capital |
|
|
| Company / Presenter |
Description |
Track |
Avatao Biotech Company (USA)
Chunlin Xin, Chief Operating Officer |
Medical diagnostics company focused on development and marketing of novel diagnostics products. |
Diagnostics |
BeiGene LLC (Beijing)
John V. Oyler, MBA, Founder & CEO |
A novel Chinese oncology portfolio R&D company. |
Drugs |
BoRui Pharmaceuticals, Inc. (Suzhou)
Jianming Yin, PhD, President |
A pharmaceutical company focusing on small molecule kinase inhibitor oncology drug discovery and development. |
Drugs |
Boston Protein Solutions (Wuxi)
Guohan Yang, PhD, President |
Novel formulation of monomeric insulin solutions as a diabetic therapeutic drug with ultra-fast hyperglycemic effect. |
Drugs |
Chiral Quest (Suzhou) Co., Ltd.
Joseph Marasco, PhD, CEO |
Creating chiral solutions for the pharmaceutical industry by developing processes for drug manufacturing. |
Services |
GinkgoPharma Co., Ltd. (Suzhou)
Songtao He, Business Development Manager |
Drug discovery and development company focused on virology and GPCR-related diseases. |
Drugs |
HOB Biotech Group Co., Ltd. (Beijing, Suzhou)
John Li, President & CEO |
In vitro diagnostics in allergy, autoimmune and infectious diseases. |
Diagnostics |
NanoChrom Diagnostics (China)
Steven Chen, PhD, CSO |
Diagnostic company focused on developing novel imaging techniques for diabetic patients with retinal disorders. |
Diagnostics |
Pacgen Biopharmaceuticals Corporation (Canada/China)
Yiu Chung (YC) Lee, PhD, CEO |
Life science technology transfer company focused on the commercial development of novel therapeutic drug candidates up to Phase II. |
Drugs |
PharmaResources (Shanghai) Co., Ltd.
Hongjian Zhang, PhD, Co-founder & COO |
Drug discovery focused organization with particular strength in medicinal chemistry and lead optimization. |
Services |
Prosperous Biopharm Co., Ltd. (Beijing)
Jin Huang, PhD, Co-founder, CTO & VP |
Drug company developing innovative protein therapeutics that address cancer and CNS diseases. |
Drugs |
ReproMed Diagnostic Technology Co., Ltd. (Shanghai)
Yang Shen, MS, Founder & Managing Director |
Leading fertility diagnostics company focused on hospitals and IVF clinics in China. |
Diagnostics |
Suzhou Arraytec Co., Ltd.
Baofu Huang, PhD, Director of Molecular Diagnostics Department |
Biotech company that researches, develops and manufactures innovative DNA detection technologies for domestic and international distribution. |
Diagnostics |
Suzhou KeyBay Biotechnology Inc.
Jian Han, MD, PhD, CSO |
Molecular diagnostic company focused on multiplex PCR technology, integrated instrument, and Bio 2.0 business model. |
Diagnostics |
Suzhou Sirnaomics BioPharmaceuticals Co., Ltd.
Alan. Y. Lu, PhD, MBA, President & General Manager |
Rapid design, discovery, delivery and development of siRNAs for therapeutic development. |
Drugs |
Vitargent (International) Biotechnology Co., Ltd.
(Hong Kong)
Eric Chen, Founder & Managing Director
|
Providing leading services for biological testing and screening toxic substances. |
Services |
Wilmington PharmaTech (Suzhou)
Hui-Yin Li, PhD, Founder, President & CEO |
Drug discovery through new and improved polymorph and co-crystalline forms. |
Drugs |
Xi’an XinTong Pharmaceutical Research Company Ltd.
James Zhang, PhD, CEO |
Emerging specialty pharmaceutical company focused on nature-based drugs including Western medicines and TCM. |
Drugs |
|
